Skip to content
Multiple Myeloma: Current Treatment Modalities episode artwork

May 13, 2008 12 min

Multiple Myeloma: Current Treatment Modalities

from Clinician's Roundtable

Host: Mark Nolan Hill, MD Guest: James Berenson, MD Extended survival outcomes are becoming increasingly common after a diagnosis of multiple myeloma. What are some of the therapies responsible for these advances, and how far are we extending survival? Further, we’re learning that certain combination therapies are more effective for certain patients. How can we determine which patients are viable candidates for a specific treatment regimen? Dr. James Berenson, founding president and chief executive officer of the Institute for Myeloma and Bone Cancer Research in West Hollywood, Calif., probes these issues and more with host Dr. Mark Nolan Hill.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Multiple Myeloma: Current Treatment Modalities

0:00 12:59

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Clinician's Roundtable?

This episode is 12 minutes long.

When was this Clinician's Roundtable episode published?

This episode was published on May 13, 2008.

Can I download this Clinician's Roundtable episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.